Axol Bioscience Science Scholarship recipient, Nataly Martynyuk, is a PhD student at the Brain Repair Centre, Department of Clinical Neurosciences, University of Cambridge, UK. Her research focuses on the actions of alpha-chimerins in mechanisms relevant to dendritic spine formation and neurodegeneration. Nataly reviews the development and degeneration of dopaminergic neurons and discusses the role of dopamine and alpha-synuclein in Parkinson's disease.
Axol Bioscience Travel Grant recipient, Marie Franquin, attended the Gordon Research Conference - Neurobiology of Brain Disorders 2016, which took place in Girona, Spain. Marie is a PhD student at the Centre for Research in Neuroscience, McGill University, Canada. Her research focuses on the role of TNF alpha on synaptic plasticity defects in neurodegenerative diseases using a mouse model and a human model of induced pluripotent stem cell derived (iPSC)-derived neurons and iPSC-derived astrocytes. Marie shares her experience of the conference where she presented her research.
Axol Bioscience sponsored Austrian Neuroscience Association (ANA) Student, Michael Stefan Unger to attend the 10th Forum for Neuroscience Societies (FENS), which took place in Copenhagen, Denmark. Michael is a PhD student at the Institute of Molecular Regenerative Medicine, Paracelsus Medical University in Salzburg, Austria. His PhD research focuses on cellular plasticity associated with amyloid-plaques and the potential role of neurogenic cells in modulating plaque pathology in Alzheimer's disease. Michael writes about his research and shares his experience of the conference.
Our understanding of the central nervous system (CNS) has grown significantly in recent years. The advent of new technologies and products have enabled us to explore not only the molecular mechanisms involved in learning, development, memory formation, electrical conductivity and synaptic function but also the onset and deterioration of these systems in neurological disorders such as epilepsy, amyotrophic lateral sclerosis (ALS), Alzheimer’s, Huntington’s and Parkinson’s diseases as well as psychiatric conditions.